disease-research Downloads
16 downloads found
As a company with innovative sequencing and genotyping technologies, CD Genomics uses the NGS Panel platform to provide a series of proprietary, ultra-high multiplexed target enrichment technology that integrates the company’s advanced panel design. The disease panels are designed to address the practical needs of various disease studies. ...
The Disease Panel provides one-stop solutions (including both services and reagents) for the study of a wide range of diseases, including cancer, inherited disease, and infection by using NGS panels or non-NGS panels, which facilitate numerous applications such as disease research, biomarker discovery, and targeted drug development. https://www.cd-genomics.com/diseasepanel/custom-ngs-panel.html ...
Our client is a global, research-driven biopharmaceutical organization that develops treatments for major diseases. Their diverse research stage biologics R&D encompasses protein, peptide and antibody candidates, and in house and collaborative projects (e.g., biologic drugs, biological products). ...
NGS has been used extensively in various disease research projects. While the cost of WGS and WES remains high for most clinical labs, targeted NGS panels have shown their effectiveness in the field of oncology. https://www.cd-genomics.com/diseasepanel/ready-to-use-ngs-panel.html ...
Gene Panel has been an invaluable tool to analyze parallel gene expression for disease-associated mutations. Here we present four powerful non-NGS technologies for gene panel that can promote your disease research, biomarker discovery, and targeted drug development. https://www.cd-genomics.com/diseasepanel/non-ngs-panel.html ...
To the greatest extent, untargeted metabolomics reflects the multiple dynamic responses of living organisms to external stimuli, pathophysiological changes, and gene mutations in metabolite levels in vivo, offering a new perspective for disease diagnosis, pathological research, new drug development, drug toxicology, and other studies. ...
CD Genomics has delivered numerous sequencing projects for pharmaceutical, biotech companies, academic institutions, and government agencies. We share our knowledge in sequencing and apply it to disease research, microbiology, food and agriculture, biomarkers, drug discovery, etc. ...
CD Genomics has developed a specialized platform for targeted sequencing of disease-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. More can be reached at https://www.cd-genomics.com/diseasepanel/predesigned-ngs-panel.html ...
A versatile low-temperature freezer installed in hospitals, blood stations, diseases control & prevention centers, research institutions, bioscience laboratories and medical laboratories. It is suitable for storing a wide variety of biological products including viruses, bacteria, red blood cells, white blood cells, skin, bone and semen as well as ocean-going supplies and electronic devices. ...
Targeted and non-targeted metabolomics take part in food identification, disease research, animal model verification, biomarker discovery, disease diagnosis, drug development, drug screening, drug evaluation, clinical research, plant metabolism research, and microbial metabolism research. ...
Targeted and non-targeted metabolomics take part in food identification, disease research, animal model verification, biomarker discovery, disease diagnosis, drug development, drug screening, drug evaluation, clinical research, plant metabolism research, and microbial metabolism research. ...
This product is suitable for the ultra low temperature storage of products in applications such as clinical, pharmaceutical,scientific research, and epidemic institutions. It also can be used in blood stations, hospitals, centers for disease control, science and research institutions, electronic and chemical laboratories, biomedical engineering institutions, and pelagic fishery companies to store ...
Services include: site visits; personnel interviews for program specific operations; and establishing electronic SOP content (MS Office), forms, checklists, and index references. Biosecurity/disease surveillance – From a basic disease surveillance program to a comprehensive bio-security program, we can help minimize the risk of your research ...
QUALITYBioscienceonsite suPPortaugmenting Your team Through onsite support services, SoBran scientific and technical professionals become a seamless extension of your team, augmenting your in-house research and development expertise. We work collaboratively with you to ensure that your research efforts are conduct-ed in the most professional and effective manner ...
Despite such a small market, Novartis developed Ilaris (canakinumab), which is now approved in more than 45 countries, including the US, EU and Switzerland.In pursuit of this therapy, Novartis scientists discovered that Muckle-Wells syndrome may share a common molecular pathway associated with other more common conditions. Institutes dedicated to researching ...